The new powder formulation gives children and adults living with Rett syndrome greater flexibility and choice in dose volume and taste
This partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets
The Phase 2 study tested two dose levels of pumitamig alongside four standard chemotherapy regimens across first
Formycon AG will develop, register, manufacture and supply the product, while Zydus Lifesciences Global FZE, United Arab Emirates will be responsible for the commercialization of FYB206 in the defined territories
The partnership also allows both companies to explore CR-001 and SKB105 as monotherapies and in combination
The project focuses on recovering high-quality polycarbonate, a valuable polymer material used in the construction of the filters
Growing patent filings and tier-2 innovators reflect expanding national research base
The partnership aims to combine TQx’s in vivo therapeutic expertise with Kytopen’s continuous flow transfection technology
Roche says the move marks a step forward in its digital transformation strategy
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
Subscribe To Our Newsletter & Stay Updated
